Dr. Dharshan is a Buffalo Spree Top Doctor! See all of our physicians who made this year's list.
Specializing In:
Internal medicine Critical care Neurocritical careResearch Interests:
Clinical research Quality Improvement Initiatives TeachingAbout Ananda Dharshan
Biography:
Some cancer patients become critically ill and develop organ failure due to complications of advanced cancer or as a result of their cancer therapy. I care for such patients by providing life support and various organ support so that they can continue to receive cancer therapy and fight cancer.
Positions
Roswell Park Comprehensive Cancer Center
- Assistant Professor of Oncology, Department of Anesthesiology
- Medical Director of the Intensive Care Unit
- Department of Internal Medicine
Jacobs School of Medicine and Biomedical Sciences, State University of New York at Buffalo
- Clinical Assistant Professor of Anesthesiology
Background
Education and Training:
- 2002 - MD - Jawaharlal Institute of Postgraduate Medicine (JIPMER), Pondicherry, India
Residency:
- 2008 -Internal medicine, Coney Island Hospital, Brooklyn, NY
Fellowship:
- 2012 - Critical care, Mount Sinai School of Medicine, New York, NY
Board Certification:
- 2013 - Neurocritical Care, United Council for Neurologic Subspecialties (UCNS)
- 2012 - Critical Care Medicine, American Board of Internal Medicine
- 2008 - Internal Medicine, American Board of Internal Medicine
Professional Memberships:
- Society of Critical Care Medicine
- American College of Chest Physicians
- American College of Physicians
Honors & Awards:
- 2022 - Buffalo Spree Top Doctors
Publications
1. Gutierrez C, Brown ART, Herr MM, Kadri SS, Hill B, Rajendram P, Duggal A, Turtle CJ, Patel K, Lin Y, May HP, Gallo de Moraes A, Maus MV, Frigault MJ, Brudno JN, Athale J, Shah NN, Kochenderfer JN, Dharshan A, Beitinjaneh A, Arias AS, McEvoy C, Mead E, Stephens RS, Nates JL, Neelapu SS, Pastores SM. The chimeric antigen receptor-intensive care unit (CAR-ICU) initiative: Surveying intensive care unit practices in the management of CAR T-cell associated toxicities. J Crit Care. 2020 Aug;58:58-64. doi: 10.1016/j.jcrc.2020.04.008. Epub 2020 Apr 15. PubMed PMID: 32361219; PubMed Central PMCID: PMC7321897.
2. Gutierrez C, Brown ART, Herr MM, Kadri SS, Hill B, Rajendram P, Duggal A, Turtle CJ, Patel K, Lin Y, May HP, Gallo de Moraes A, Maus MV, Frigault MJ, Brudno JN, Athale J, Shah NN, Kochenderfer JN, Dharshan A, Beitinjaneh A, Arias AS, McEvoy C, Mead E, Stephens RS, Nates JL, Neelapu SS, Pastores SM. The chimeric antigen receptor-intensive care unit (CAR-ICU) initiative: Surveying intensive care unit practices in the management of CAR T-cell associated toxicities. J Crit Care. 2020 Aug;58:58-64. doi: 10.1016/j.jcrc.2020.04.008. Epub 2020 Apr 15. PubMed PMID: 32361219; PubMed Central PMCID: PMC7321897.